Objective To examine alterations in maternal vascular structure and function during normal pregnancy. 
INTRODUCTION
The maternal cardiovascular system changes rapidly during pregnancy in order to provide sufficient uteroplacental circulation and to optimize fetal growth. Hormonal changes induce maternal vasodilatation and plasma expansion 1 , and a reduction in peripheral vascular resistance and blood pressure (BP) can already be observed after only a few weeks' gestation 2 . Blood flow to many organs, especially the kidneys and uterus, increases markedly during normal pregnancy and demands a rapid increase in cardiac output, which is achieved by an increase in heart rate and stroke volume 3 . Maladaptation of the cardiovascular system to pregnancy is associated with hypertensive disorders during pregnancy, such as pre-eclampsia, and impaired fetal growth 4 -7 . A reproductive history, including normal gestation, is a protective factor against future cardiovascular disease 8 and, conversely, hypertensive pregnancy-related disorders are associated with an increased future cardiovascular risk 9 -11 . The early identification of pregnant women and offspring at risk is important for taking appropriate preventive actions. Better knowledge about normal cardiovascular responses to pregnancy could provide new insights into the maternal and fetal risks based on each woman's cardiovascular adaptation to pregnancy.
Some aspects of vascular function have been studied thoroughly during pregnancy, whereas other aspects remain insufficiently explored 12, 13 . In particular, few studies have examined different aspects of vascular function simultaneously and longitudinally in the same group of women during normal pregnancy. Thus, our objective was to study alterations in vascular structure and function, ranging from the aorta to microcirculation, during normal pregnancy. Measurements were obtained in the same participants during each trimester and in the non-pregnant state 9 months after delivery.
PATIENTS AND METHODS

Study design and subjects
This prospective longitudinal observational study on cardiovascular alterations during and after pregnancy was approved by the Regional Ethics Committee in Stockholm, Sweden. All subjects provided written informed consent to participate. For the purpose of the present investigation, 60 healthy, non-smoking nulliparous women with normal BP at inclusion and no medical history of any disease known to impact vascular function were enrolled at our institution during the routine first-trimester combined fetal ultrasound and biochemical screening. Further inclusion criteria were: singleton pregnancy, regular menstrual cycles, reliable data for last menstrual period and no observed malformation of the fetus at inclusion. All women were examined at 11-14, 22-24 and 32-34 weeks' gestation. Examinations in the non-pregnant state were performed 9 months after delivery. We have reported previously on the association between first-trimester maternal vascular function and fetal growth in this study population 14 . Information on medical history, parity, height and weight of all participants was collected from charts at the maternal healthcare units. Blood samples were collected at the time of the vascular examinations at 11-14 weeks' gestation and analyzed for fasting glucose, cholesterol and creatinine using standard procedures. Information on gestational age at delivery, birth weight, neonatal gender and any pregnancy complications were obtained from medical charts from the delivery wards. Birth-weight centile was calculated using a customized centile calculator, taking into account the gestational age at delivery, maternal booking weight, height, parity, ethnicity and sex of the neonate 15 .
Blood pressure measurements and pulse-wave analysis
Brachial BP was calculated as the mean of three readings obtained 1 min apart with the participant in the supine position, using an oscillometric device (Omron 705IT, Omron Healthcare, Kyoto, Japan) on the right arm with an appropriately sized cuff. Pulse pressure was calculated as systolic -diastolic BP, and mean arterial pressure as diastolic BP + (systolic -diastolic BP)/3.
Pulse-wave analysis was performed using a SphygmoCor device (AtCor Pty, West Ryde, NSW, Australia) according to current recommendations 16 . Radial artery waveforms were obtained by applanation tonometry and calibrated using brachial systolic and diastolic BP; the central aortic waveform was calculated by device software using the generalized transfer function, and central BP values and heart rate were derived. The augmentation index was calculated through the software and corrected to a heart rate of 75 bpm throughout. Recordings were repeated at the level of the common carotid artery (CCA) and the femoral artery, and pulse-wave velocity (PWV) was calculated from the direct (carotid-to-radial and carotid-to-femoral) path length.
Examination of carotid arteries
Ultrasonographic examinations of the left and right CCA were performed using a Vivid 7 Dimension ultrasound device with a 5-or 7-MHz linear transducer (GE Medical Systems, Horten, Norway) with the subjects in a supine position, as described elsewhere 17 . An electrocardiogram signal synchronized the image analysis to the end of diastole. The vessels were scanned at the level of the bifurcation, and three B-mode images from the longitudinal view, as well as a short sequence of real-time images, were recorded on videotape. CCA intima-media thickness was measured along a 10-mm-long segment just proximal to the carotid bulb. The intima-media thickness was assessed as the mean value of the distance from the leading edge of the lumen-intima interface to the leading edge of the media-adventitia interface of far and near walls in the right and left CCAs.
Endothelial function
Postischemic hyperemia-induced flow-mediated dilatation (FMD) of the forearm vascular bed, considered to reflect endothelium-dependent vasodilatation, was assessed in the non-dominant arm, according to current recommendations 18 . Vasodilatation was induced by inflation of a pneumatic tourniquet placed around the forearm to a pressure of 250 mmHg for 5 min, followed by its release. Brachial artery blood flow and diameter were measured proximal to the cuff using a Vivid 7 Dimension ultrasound device with a 9-MHz linear transducer. All images were stored for later analyses. The mean values of three measurements of arterial diameter obtained at end diastole were calculated at rest and at 30, 60 and 90 s after cuff release. After a washout period of at least 10 min to regain stable resting conditions, 0.4 mg glyceryl trinitrate (GTN) (Nitrolingual, G Pohl-Boskamp GmbH, Hohenlockstedt, Germany), administered as a sublingual spray, was used to assess endothelium-independent vasodilatation. Relative changes in brachial artery diameter after administration of GTN were calculated from rest to 4 min following drug administration. In order to properly assess endothelial function, we calculated the endothelial function index as the ratio of the maximum relative increase in FMD/GTN-induced vasodilatation, as proposed previously 19 . In our laboratory, the coefficient of variation for FMD is 15%. Local shear rate was calculated as blood velocity/brachial artery internal diameter.
Endothelium-dependent and -independent forearm skin microvascular dilatation was assessed using laser Doppler perfusion imaging and iontophoretic administration of acetylcholine (ACh) and sodium nitroprusside (SNP) 20 . Electrode chambers (LI611 Drug Delivery Electrode Imaging; Perimed, Järfälla, Sweden) were attached to the volar side of the forearm and filled with 0.5 mL of either ACh (2%) or SNP (2%). A battery-powered iontophoresis controller (Perilont 382b; Perimed) provided a direct current (0.1 mA for 60 s) for drug iontophoresis. Skin microvascular flux (expressed in arbitrary units) before, during and after iontophoresis was recorded continuously (PeriScan PIM II; Perimed) up to 10 and 14 min after iontophoresis of ACh and SNP, respectively, and peak microvascular flux was determined. The absolute and percentage differences in microvascular flux following ACh and SNP administration were calculated. In order to assess endothelial-dependent vasodilatation and account for non-specific vascular reactivity in the skin microcirculation, a microvascular endothelial function index was calculated as peak ACh/peak SNP. In our laboratory, coefficients of variation for peak microvascular flux after iontophoreses of ACh and SNP are 11% and 20%, respectively.
Statistical analysis
Results are presented as mean ± SD, or median and range if data were skewed. The Shapiro-Wilks test was used to test the distribution for normality. Longitudinal data were analyzed using a linear mixed model with Bonferroni post-hoc test for pairwise comparisons. Comparisons of augmentation index and PWV measurements between each time point were adjusted for mean arterial pressure and heart rate. A two-sided probability of P < 0.05 was considered significant. SPSS version 22 (SPSS Inc., Chicago, IL, USA) was used for data analysis.
The sample size of this prospective longitudinal study was calculated from a hypothesis to study the association between first-trimester maternal vascular function and fetal size, and we estimated that a study population of 25 subjects was needed in each group to detect a 15% difference in FMD (with 2α = 0.05 and β = 0.80) 14 . Thus, we included 60 women to account for participants who would not complete all investigations and technical or analytical problems.
RESULTS
Study population
A total of 60 women were enrolled in the study; two had lethal malformation of the fetus and four developed complications during pregnancy (two cases of pre-eclampsia and two of intrauterine growth restriction < 5 th percentile), and were excluded. Of the remaining participants, some declined full investigations due to discomfort or did not complete all visits. Thus, 52, 49 and 45 women participated in all examinations in the first, second and third trimesters, respectively, and 31 at 9 months after delivery. Participants who dropped out of the study showed no differences in background data or neonatal outcome compared with the other participants (data not shown). Maternal characteristics at inclusion in the first trimester and neonatal outcome are shown in Table 1 . Subgroup analyses of women who did not complete all study visits showed no differences in background characteristics, vascular function or neonatal outcome compared with participants who completed all investigations. Detailed information is available in Table S1 .
Blood pressure and heart rate
There were small significant changes in brachial systolic, diastolic and mean arterial BP during pregnancy, with an initial decrease in the first and second trimesters followed by an increase (Figure 1 ). Brachial pulse pressure increased during the first two trimesters, whereas central pulse pressure decreased. Heart rate increased with each trimester from 67 ± 7 bpm in the first trimester to 77 ± 10 bpm in the third trimester (P < 0.001).
Arterial structure and stiffness
Carotid-femoral PWV (adjusted for mean arterial pressure and heart rate) decreased during pregnancy, whereas carotid-radial PWV decreased initially but increased above non-pregnant levels by the end of pregnancy (Figure 2 ). Augmentation index (corrected to a heart rate of 75 bpm) was significantly reduced during pregnancy. CCA diameter increased from 5.83 ± 0.41 mm at baseline to 6.23 ± 0.36 mm in the third trimester, whereas CCA intima-media thickness decreased from 0.55 ± 0.06 mm in the non-pregnant state to 0.51 ± 0.04 mm in the third trimester. 
Endothelial function in forearm vascular bed and skin microcirculation
During pregnancy, FMD increased and non-specific vasodilatation in response to GTN was reduced ( Figure 3) . Thus, endothelium-dependent vasodilatation, as assessed by the endothelial function index (FMD/GTN), increased during pregnancy. Detailed information is available in Table S2 . In the forearm skin microcirculation, ACh-induced endothelium-dependent microvascular reactivity increased during pregnancy (P < 0.01) (Figure 3) . SNP-induced endothelium-independent microvascular reactivity showed an increasing trend (P = 0.07). The resulting ratio of peak ACh:peak SNP was unchanged during pregnancy (P = 0.15). Detailed information is available in Table S3 . Figure S1 illustrates how the relative changes in the various parameters of vascular structure and function related to each other during pregnancy.
DISCUSSION
There are three major findings of this longitudinal study on maternal vascular structure and function during and after normal pregnancy relating to the effects on central BP, vascular compliance and endothelial function. First, brachial BP decreased somewhat in early pregnancy, followed by an increase in the third trimester, in accordance with most studies during normal pregnancy 21, 22 . Central BP decreased more than brachial BP during the first stage of pregnancy. Our results confirm and extend the results of previous cross-sectional and longitudinal studies 12, 22, 23 , and suggest that central BP is reduced more than brachial BP during early pregnancy. Central BP and central pulse pressure are more closely related to cardiovascular risk and future disease than brachial BP 24 . Thus, measuring central BP during pregnancy might be more useful than measuring brachial BP to identify women with high risk of complications.
Second, carotid-femoral PWV, a marker of aortic stiffness 25 , decreased during pregnancy. Previous studies reporting carotid-femoral PWV during pregnancy have not been consistent 23 . Our findings provide new information in support of reduced aortic stiffness during pregnancy. Pulse-pressure amplification, as compared with brachial pulse pressure, reflects pulsatile flow and gives information about central hemodynamic (large artery stiffness) and microvascular (site of wave reflection depending on geometry and vasomotor tone) damage. Thus, central pulse pressure will, to some extent, reflect aortic stiffness. Accordingly, central pulse pressure decreased during pregnancy, in accordance with previous cross-sectional 26 and longitudinal 12, 13 studies. The relative changes in augmentation index were larger than those observed for carotid-femoral PWV, suggesting P-values in graphs relate to trend for change over time, by linear mixed model. Significant differences between values in each trimester and baseline at 9 months postpartum are indicated by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001). Statistical evaluation of augmentation index and pulse-wave velocity included adjustment for mean arterial blood pressure and heart rate.
that carotid-femoral PWV and augmentation index provide different information; PWV reflects aortic stiffness, whereas augmentation index is determined by endothelial dysfunction and increased arterial resistance, and may be a more sensitive early marker of arterial stiffness in younger individuals 27 . In contrast to carotid-femoral PWV, carotid-radial PWV decreased until mid-pregnancy and then increased until term, suggesting an early reduction in aortic stiffness during normal pregnancy. This, similar to the changes in brachial BP, may reflect the increase in peripheral resistance in late pregnancy. An attenuated increase in vascular compliance during early pregnancy may predict maternal and fetal complications 28, 29 . Thus, assessment of aortic stiffness may be of value to identify a pregnancy at high risk.
We observed a progressive increase in the diameter of conduit arteries (CCA and brachial artery) during pregnancy. CCA intima-media thickness decreased, possibly due to passive distension. Microvascular reactivity increased, indicating an increased vasodilator capacity also in the microcirculation. This is consistent with our findings of an increased aortic compliance. Previous studies on CCA diameter and intima-media thickness during normal pregnancy are few, cross-sectional or only performed in late pregnancy 30, 31 . Our study seems to be the first to investigate CCA intima-media thickness longitudinally during normal pregnancy.
Third, we observed an early and persistent improvement in endothelial function of the brachial artery. An increased FMD during pregnancy is in accordance with previous cross-sectional 31, 32 and small longitudinal studies not extending postpartum 32, 33 , and may be related to increased vascular nitric oxide availability during pregnancy 34 . It is important to measure indices of both endothelium-dependent and -independent vasodilatation, as an increased FMD could be due to increased non-specific vascular smooth muscle responsiveness 35 . Vessel diameter is inversely related to the vascular responses to postischemic hyperemia and GTN 36 . This inverse relationship with vessel diameter is a probable reason for the apparent reduced response to GTN. Only one previous cross-sectional study examined both endothelium-dependent and -independent vasodilatation during pregnancy, and showed improved endothelium-dependent and unchanged endothelial-independent vasodilatation, when compared with non-pregnant women 37 P-values in graphs relate to trend for change over time, by linear mixed model. Significant differences between values in each trimester and baseline at 9 months postpartum are indicated by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001). AU, arbitrary unit.
extends those findings and indicates a prominent and early improvement in endothelial function during pregnancy. Consistent with our findings in the forearm skeletal muscle vasculature, microvascular reactivity to ACh increased during pregnancy, suggesting increased endothelium-dependent microvascular function. In contrast to the brachial artery, however, the response to SNP suggests that non-specific microvascular reactivity is also increased during pregnancy. This is in agreement with findings from one longitudinal study 38 , but very few have investigated microvascular reactivity during normal pregnancy. Impaired skin microvascular function is related to cardiovascular risk factors 39 . We have reported previously a positive relationship between microvascular reactivity in the first trimester and fetal growth 14 . Others have shown altered endothelium-dependent microvascular reactivity in pregnancies complicated by hypertensive disorders or intrauterine growth restriction, but results are divergent 40, 41 . Thus, our findings suggest that microvascular reactivity contains important information regarding the risk of pregnancy-related complications.
This study has some strengths. First, several aspects of the arterial vasculature were examined simultaneously and this was repeated in the same participants during each trimester and in the non-pregnant state 9 months after delivery. Furthermore, we present a greater range of vascular measures than in earlier publications 23, 33, 42 . Second, we simultaneously examined endothelial function by two well-established methods, and evaluated both endothelium-dependent and -independent mechanisms, which has not often been performed in pregnancy. However, the study has important limitations that should be mentioned. First, we did not obtain measurements representing the non-pregnant state before the index pregnancy. Data representing the non-pregnant state were obtained 9 months after delivery when all women had recommenced menstrual cycles (although menstrual phase at the examination was not recorded 43 ). Previous studies on vascular function have reported a persistent decrease in central BP and PWV years after a normal pregnancy 44, 45 . This might have led us to underestimate those results. Second, our results should be interpreted with care due to the small sample size. Finally, a limitation includes missing data in the final study visit; however, all statistical evaluations took this into account to minimize potential confounding.
In summary, the blood volume expansion needed for sufficient fetal growth appears to be accommodated by early and marked changes in the maternal vascular system. This volume expansion, probably initiated by placental hormones, seems to be dependent on normal adaptive endothelial and vascular function. Failure to accommodate these alterations may identify women at high risk of pregnancy-related complications and may be the true cause of late pre-eclampsia, rather than placental issues 46 . Early changes in arterial stiffness and endothelial function may thus provide useful information regarding maternal and fetal risks during pregnancy or later in life.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1
Maternal characteristics at inclusion in first trimester and pregnancy outcomes in women who did and did not complete all four study visits Table S2 Forearm vascular bed measurements in first, second and third trimesters, and in a non-pregnant state at 9 months postpartum in 52 women with normal pregnancy Table S3 Forearm skin microcirculation measurements in first, second and third trimesters, and in a non-pregnant state at 9 months postpartum in 52 women with normal pregnancy Figure S1 Changes in vascular structure and function during pregnancy, presented as percentage change from a non-pregnant state at 9 months postpartum, by assessment of: (a) endothelial function, (b) arterial structure, (c) arterial stiffness and (d) blood pressure and heart rate.
